CA-MCAFEE
21.8.2024 06:02:29 CEST | Business Wire | Press release
McAfee, a global leader in online protection, today announced the launch of McAfee® Deepfake Detector, the latest addition to the company’s suite of AI-powered products. With AI-created videos, or deepfakes, flooding the internet and circulating across social media, we now live in a world where seeing and hearing are no longer believing. To combat the rise in AI scams and misinformation, McAfee is working with Lenovo to bring powerful AI-based deepfake detection capabilities to customers purchasing select Lenovo AI PCs, starting today. To help educate consumers, McAfee is also launching the Smart AI Hub with resources and interactive elements to build awareness of deepfakes and AI-driven scams.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240820483013/en/
McAfee Deepfake Detector dashboard (Graphic: Business Wire)
The advent of AI has changed the game for cybercriminals, who are creating more convincing, personalized, AI-generated scams at scale. The impact of a deepfake scam can be life-altering, with victims reporting losses ranging from $250 to over half a million dollars.1 While not all AI-content is created with malicious intent, the ability to know if a video is real or fake helps consumers make smart and well-informed decisions.
“Knowledge is power, and this has never been truer than in the AI-driven world we’re living in today,” said Roma Majumder, Senior Vice President of Product at McAfee. “No more wondering, is this Warren Buffet investment scheme legitimate, does Taylor Swift really want to give away cookware to fans, or did a politician actually say these words? The answers are provided to you automatically and within seconds with McAfee Deepfake Detector.”
“At McAfee, we’re inspired by the transformative potential of AI and are committed to helping shape a future where AI is used for good. Teaming up with Lenovo boosts our ability to deliver the most effective, automated, AI-powered deepfake detection, offering people a powerful digital guardian on their PCs. Together, we’re able to harness AI in new and revolutionary ways, empowering individuals with the most advanced deepfake detection so they can navigate the evolving online world safely and confidently.”
“The collaboration between Lenovo and McAfee combines the unique expertise of two global leaders to deliver innovative solutions that offers consumers more trust in the content they view online,” said Igor Bergman, Vice President of Lenovo Cloud and Software, Intelligent Devices Group. “Data shows that nearly two-thirds of people (64%) are more concerned about deepfakes now than they were a year ago2. Lenovo’s expertise as an end-to-end technology solutions leader and McAfee’s experience in AI-powered online protection perfectly complement each other, optimizing hardware and software capabilities for the benefit of the consumer.”
Enhanced performance, with privacy safeguards
With McAfee® Deepfake Detector now available exclusively on select Lenovo AI PCs, consumers who opt in are alerted within seconds if AI-altered audio is detected in videos, without relying on laborious manual video uploads. Trained on close to 200,000 samples and counting and leveraging the power of select Lenovo AI PCs equipped with an NPU, McAfee’s AI detection models perform the entire identification process – known as inference – directly on the PC, maximizing on-device processing to keep private user data off the cloud. McAfee does not collect or record a user’s audio in any way, and the user is always in control and can turn audio detection on or off as desired.
By leveraging the NPU and performing analysis on-device, McAfee provides comprehensive privacy and boosts processing speed when compared to cloud-based usage and improves battery life. These advancements significantly enhance the consumer experience, allowing people to make informed decisions about the content they view and protecting them against cybercrooks manipulating video audio without compromising the speed of their PC. This ensures consumers can use their PC as usual – whether they’re gaming, browsing, or watching videos – while McAfee Deepfake Detector works quietly in the background, protecting people against deceptions and alerting them to potential scams without compromising performance.
Availability and Pricing
McAfee® Deepfake Detector is available for English language detection in select new Lenovo AI PCs3, ordered on Lenovo.com and select local retailers beginning August 21, 2024, in the US, UK, and Australia.
Lenovo AI PC customers receive a free 30-day trial of McAfee Deepfake Detector with US pricing starting at $9.99 for the first year.
McAfee Smart AI™ Hub
The McAfee Smart AI™ Hub at McAfee.ai is the online, go-to destination for the latest information and educational content related to AI and cybersecurity, with a focus on deepfakes and AI-driven scams. The Hub also empowers consumers to join the fight against scams by submitting suspicious videos for analysis by McAfee’s advanced AI-powered deepfake detection technology. Insights and trends identified through this analysis will be used to further educate the public, enriching societal understanding and awareness of deepfakes and other artificially generated content, and enhancing everyone’s ability to navigate and stay safe in a digital world increasingly shaped by artificial intelligence.
About McAfee
McAfee Corp. is a global leader in online protection for consumers. Focused on protecting people, not just devices, McAfee’s consumer solutions adapt to users’ needs in an always online world, empowering them to live securely through integrated, intuitive solutions that protect their families, communities, and businesses with the right security at the right moment. For more information, please visit https://www.mcafee.com/.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
1 https://www.nytimes.com/interactive/2024/08/14/technology/elon-musk-ai-deepfake-scam.html
2 McAfee conducted research in January and February of this year, across multiple countries to understand how artificial Intelligence and technology are changing the future. The study was conducted by MSI- ACI with 1,000+ consumers in each of the following countries: US, UK, France, Germany, Australia, India, Japan.
3 Lenovo is a trademark of Lenovo.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240820483013/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom